A product label for Lamictal XR (Lamotrigine) Extended-Release Tablets. The label is orange and green in color and has the brand name "Lamictal" written in bold white letters at the top. Below that there is a description of the product which states that it is for patients taking carbamazepine phenytoin phenobarbital or primidone and not taking valproate.
The label also includes information about the patient titration kit which includes 14 tablets 14 100mg tablets and 7 200mg tablets. There is also a warning label that reads "Dispense the accompanying medication guide to each patient."
At the bottom of the label there are two buttons - "Caution" and "Verify Product Dispensed".
Description 
Type
Category
-
Date
2015
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A bar graph that shows the results of a study about EXALGO. The graph is divided into three sections.<br /><br />The first section is titled "Studies show switching to EXALGO could provide long lasting analgesia" and shows that in its 12-week pivotal trial EXALGO reduced pain intensity at study endpoint and throughout the trial. The second section is labeled "Conversion/Treatment Phase" and has a blue arrow pointing to the left side of the graph. The third section is labeled "6.4 Week 1 [etc.]"](https://oida-resources-images.azureedge.net/public/full/20a0a652-bcb7-4362-871c-1be2d99a256b.jpeg)
